Current status and challenges of CAR-T cell therapy in the treatment of haematological cancer
Chimeric Antigen Receptor T (CAR-T) cell therapy is a promising cellular immunotherapy that involves the use of genetically modified T cells to target and combat hematological malignancies. This approach has shown significant effectiveness and has emerged as a key area of interest in oncological tre...
Saved in:
| Main Author: | Yu Mengqi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
EDP Sciences
2025-01-01
|
| Series: | BIO Web of Conferences |
| Online Access: | https://www.bio-conferences.org/articles/bioconf/pdf/2025/33/bioconf_icfsb2025_02001.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer
by: Hany E. Marei, et al.
Published: (2025-01-01) -
CAR-T cell therapy for cancer: current challenges and future directions
by: Inés Zugasti, et al.
Published: (2025-07-01) -
Tandem CAR-T cell therapy: recent advances and current challenges
by: Sara Gómez-Melero, et al.
Published: (2025-02-01) -
CAR-T cell therapy for hepatocellular carcinoma: current trends and challenges
by: Yexin Zhou, et al.
Published: (2024-11-01) -
CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives
by: Jincai Zhou, et al.
Published: (2024-12-01)